Kenvue Inc. $KVUE Stock Holdings Increased by Creative Financial Designs Inc. ADV

Creative Financial Designs Inc. ADV grew its position in shares of Kenvue Inc. (NYSE:KVUE) by 408.5% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 42,726 shares of the company’s stock after buying an additional 34,323 shares during the period. Creative Financial Designs Inc. ADV’s holdings in Kenvue were worth $693,000 as of its most recent SEC filing.

Several other hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. raised its position in shares of Kenvue by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 233,246,267 shares of the company’s stock valued at $4,881,844,000 after acquiring an additional 4,101,880 shares in the last quarter. Geode Capital Management LLC boosted its holdings in Kenvue by 1.2% in the second quarter. Geode Capital Management LLC now owns 49,001,887 shares of the company’s stock worth $1,021,267,000 after purchasing an additional 604,953 shares during the period. Independent Franchise Partners LLP increased its stake in Kenvue by 233.4% during the second quarter. Independent Franchise Partners LLP now owns 31,265,574 shares of the company’s stock valued at $654,388,000 after purchasing an additional 21,886,537 shares during the last quarter. American Century Companies Inc. increased its stake in Kenvue by 38.6% during the second quarter. American Century Companies Inc. now owns 30,265,020 shares of the company’s stock valued at $633,447,000 after purchasing an additional 8,436,166 shares during the last quarter. Finally, Norges Bank acquired a new stake in shares of Kenvue during the second quarter worth $537,418,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Insider Buying and Selling

In related news, Director Jeffrey C. Smith purchased 3,200,000 shares of the company’s stock in a transaction on Friday, December 12th. The shares were bought at an average cost of $17.37 per share, for a total transaction of $55,584,000.00. Following the transaction, the director owned 27,307,632 shares of the company’s stock, valued at $474,333,567.84. This represents a 13.27% increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available through this link. Insiders own 1.68% of the company’s stock.

Wall Street Analyst Weigh In

KVUE has been the subject of several research reports. UBS Group lifted their price target on shares of Kenvue from $17.00 to $19.00 and gave the company a “neutral” rating in a report on Wednesday, February 18th. Citigroup lifted their target price on Kenvue from $18.00 to $20.00 and gave the company a “neutral” rating in a research note on Wednesday, February 18th. Zacks Research upgraded Kenvue from a “strong sell” rating to a “hold” rating in a research report on Wednesday, November 26th. Barclays raised their price target on Kenvue from $17.00 to $18.00 and gave the stock an “equal weight” rating in a report on Monday, November 10th. Finally, Canaccord Genuity Group upped their price objective on Kenvue from $17.00 to $18.00 and gave the stock a “hold” rating in a research note on Wednesday, February 18th. Three analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $19.50.

Kenvue Stock Up 0.6%

KVUE opened at $19.11 on Monday. The stock’s 50 day moving average price is $17.72 and its 200 day moving average price is $17.50. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.96 and a quick ratio of 0.68. The stock has a market cap of $36.62 billion, a P/E ratio of 24.81, a P/E/G ratio of 4.38 and a beta of 0.59. Kenvue Inc. has a 12 month low of $14.02 and a 12 month high of $25.17.

Kenvue (NYSE:KVUE) last announced its quarterly earnings results on Tuesday, February 17th. The company reported $0.27 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.22 by $0.05. The company had revenue of $3.78 billion during the quarter, compared to analyst estimates of $3.68 billion. Kenvue had a return on equity of 19.72% and a net margin of 9.72%.The firm’s quarterly revenue was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.26 EPS. As a group, research analysts predict that Kenvue Inc. will post 1.14 earnings per share for the current year.

Kenvue Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, February 25th. Investors of record on Wednesday, February 11th were given a $0.2075 dividend. This represents a $0.83 dividend on an annualized basis and a yield of 4.3%. The ex-dividend date was Wednesday, February 11th. Kenvue’s dividend payout ratio is currently 107.79%.

About Kenvue

Kenvue is a consumer health company that was established as a standalone, publicly traded business after separating from Johnson & Johnson. Listed on the New York Stock Exchange under the symbol KVUE, Kenvue focuses on the development, manufacture, marketing and distribution of consumer health and personal care products across a range of categories including skin and beauty care, baby care, oral care, wound care and over‑the‑counter medicines.

The company owns and markets a portfolio of widely recognized consumer brands, including names familiar to global shoppers across retail and pharmacy channels.